RT Journal Article
SR Electronic
T1 Forecasting sub-national trends in COVID-19 vaccine uptake in the UK
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.12.17.20248382
DO 10.1101/2020.12.17.20248382
A1 de Figueiredo, A.
YR 2021
UL http://medrxiv.org/content/early/2021/04/01/2020.12.17.20248382.abstract
AB The rollout of COVID-19 vaccines has begun to at-risk populations around the world. It is currently unclear whether rejection of the vaccine will pose challenges for achieving herd/community immunity either through large-scale rejection or localised pockets. Here we predict uptake of the vaccine at unprecedented spatial resolution across the UK using a large-scale survey of over 17,000 individuals. Although the majority of the UK population would likely take the vaccine, there is substantial heterogeneity in uptake intent across the UK. Large urban areas, including London and North West England, females, Black or Black British ethnicities, and Polish-speakers are among the least accepting. This study helps identify areas and socio-demographic groups where vaccination levels may not reach those levels required for herd immunity. Identifying clusters of non-vaccinators is extremely important in the context of achieving herd immunity as vaccination “cold-spots” can amplify epidemic spread and disproportionately increase vaccination levels required for herd protection.Competing Interest StatementThe Author is involved in Vaccine Confidence Project collaborative grants with GlaxoSmithKline outside the submitted work.Funding StatementThis project was funded by the Imperial College COVID-19 Response Fund.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Approval for this study was obtained via the Imperial College Research Ethics Committee on 24 July 2020 with reference 20IC6133.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData for this study are not currently publicly available. The Author intends to make the data open access in early 2021.